CCMG
BIVV

Clark Capital Management Group’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Clark Capital Management Group’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-17,356
Closed -$936K – 318
2017
Q4 		$936K Buy
17,356
+8,305
+92% +$454K 0.03% 208
2017
Q3 		$517K Buy
+9,051
New +$530K 0.02% 246

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Clark Capital Management Group's BIVV Position: Q1 2018 in Review

Clark Capital Management Group sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 17,356 shares — an estimated $936K sold.

Clark Capital Management Group first reported a position in BIVV in Q3 2017 and held it in 2 quarters. The position peaked at $936K in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Clark Capital Management Group reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Clark Capital Management Group sold 17,356 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $936K.
  • Clark Capital Management Group first reported a position in Bioverativ Inc. Common Stock in Q3 2017 and held it in 2 quarters.
  • Clark Capital Management Group's Bioverativ Inc. Common Stock position peaked at $936K in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Clark Capital Management Group's 13F filing for Q1 2018, filed 15 May 2018.